BioSpace News Archive

Verastem, Inc. today announced a collaboration with The Leukemia & Lymphoma Society® (LLS), to accelerate the development of duvelisib for the treatment of patients with peripheral T-cell lymphoma

Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced that it will report financial results for the quarter and nine months ended September 30, 2018 and host a conference call and webcast at 4:30pm Eastern Time on Wednesday, November 14, 2018.

Positive safety and efficacy trends of AR-301 in Phase 1/2a clinical trial was presented at the 31st Annual Congress of the European Society of Intensive Care Medicine

510(k) clearance for artificial intelligence software developed to enhance an acute care physician’s ability to identify and prioritize brain bleed stroke or head trauma

Previously the Johnson & Johnson Diabetes Institute; Remains Committed to Transforming Diabetes Care through World-Class Experiential Learning

DaVita Kidney Care is a leading provider of kidney care services in the United States

Aflac, the leader in voluntary insurance sales at the worksite in the United States and a committed corporate ally in the cause to help defeat childhood cancer, today introduced its 2018 Aflac Holiday Duck.

A team of researchers from the Dr. Rath Research Institute in California has developed a cancer vaccine effective in reducing tumor growth.

Biorem’s complete third quarter financial statements and MD&A have been filed on SEDAR

Booth 421 next to the Health Innovation Pavilion